Federal Reserve Chairman Jerome Powell stuck to his script that it is not yet time to begin cutting interest rates on Wednesday in the first of two appearances this week on Capitol Hill. The Fed has taken interest levels to their highest in decades in a battle to bring inflation down to the central bank’s 2% annual target. Although significant progress has been made, prices remain…
Whether you’re a new or seasoned investor, you’re probably wondering what to expect from the stock market and other asset classes in 2024. Unless you have ESP, it’s impossible to tell what the year will bring. But there are several trends that are already taking shape in the first two months of the new year. Here are five surprising investing…
Recently, more and more companies are offering AI-powered solutions and products every day to ride the wave of AI stocks. Yet for investors, this can be confusing, as just because a company claims to incorporate AI, doesn’t necessarily mean profitability. Now, more than ever, understanding the value an AI brings to a technological product or service is critical for investing. The projects investors…
The Biden administration’s pause on approvals for new liquified natural gas (LNG) liquefaction projects has tanked the price of natural gas. The low prices will curtail production, eventually leading to higher prices. This is the time to invest to profit from the price recovery – and here are my favorite ways to do it… This post appeared at Dividend Stocks…
I’ve had an opportunity to once again sit down with Kai Hoffmann on Soar Financial to discuss the stock market, commodities, technology, etc. Has the bull finally broken its leg or is it gearing up for new higher-highs? I invite you to watch to learn more. This post appeared first on Technical Traders Ltd.
While targeting the therapeutic side of the healthcare sector can be quite lucrative, nothing matches the excitement of biotech penny stocks. This is a good time to remind you of all the reasons you shouldn’t buy biotech penny stocks. While many of these companies may claim advanced clinical data and whatnot, the reality is that many, if not most players…
The stock market is off to a solid start of 2024, with the S&P 500 index gaining more than 5% yea to date. Software giants are leading the charge thanks to the continued boom in artificial intelligence (AI) tools. But not every big winner is a household name, and some of the best buy-and-hold investments in today’s tech sector are not so…
The global pharma market is expanding with rising healthcare demand and precision medicine advances, fueled by a growing focus on health and longevity. Thus, investors could consider investing in the following robust pharma stocks given their solid growth prospects. In 2024, pharma companies are focused on reinventing strategies to drive returns, leveraging innovations while optimizing operational costs, and pursuing strategic…
If you’re a dyed-in-the wool dividend investor (like me!), you’ve likely taken a look at the big gains folks are reaping on AI stocks … and resigned yourself to missing out on the whole thing. The good news is we don’t have to miss out—instead, we’re going to go one floor up from the “first-level” options that most folks buy…
The Bill & Melinda Gates Foundation Trust’s investment portfolio is worth $42.3 billion as of Dec. 31, according to the trust’s latest 13F filing with the Securities and Exchange Commission on Feb. 14. That’s up from $38.9 billion as of Sept. 30. What changed with the Gates Foundation Trust’s portfolio in the last three months of 2023? The trust pared…